Authors
Latest:
ASRS 2019 Street Team: W. Lloyd Clark, MDICYMI: Dr. Clark breaks down the results of the PANORAMA Study
Latest:
Diagnosing early-stage AMD with a dark adaptation deviceA dark adaptometer (AdaptDx; MacuLogix Inc) can aid in the diagnosis of early-stage, or subclinical, age-related macular degeneration before visual loss occurs and even before structural changes are observed, and adds to the information obtained from retina cameras and OCT imaging.
Latest:
Applying AI in fundus imagesFDA decision changes scope of healthcare delivery; increases patient access to early detection of DR
Latest:
Nailing intravitreal implant injectionsTreating diabetic macular edema (DME) has evolved from the ETDRS-style focal/grid laser being the standard of care since 1985 to the modern era of pharmacotherapy-with anti-vascular endothelial growth factor (VEGF) injections now taking center stage as primary treatment for most patients.
Latest:
Retina surgeon’s AMD regimen at center of Medicare fraud caseEarlier this month, a jury convicted West Palm Beach retina surgeon Solomon Melgen, MD, on 67 counts of Medicare fraud. This high-profile case hit very close to home, as myself and another retina specialist from my own community were on opposing sides of the case.
Latest:
Novel therapies abound in pipelineThe importance of novel therapies for ocular disease is a given. However, as most novel therapies are financed by the private sector, it is fortunate that investors find ophthalmology a worthwhile investment.
Latest:
Diagnosing and treating MacTel degenerative retinal diseaseIdiopathic macular telangiectasia (MacTel) is bilateral condition characterised by ectatic capillaries of the macula and atrophy of the neurosensory retina. Familiarity with the distinctive intraretinal cavitation on SD-OCT in type 2, the most common type, is key for correct diagnosis.
Latest:
Scleral buckle technique using PPV, laser photocoagulationScleral buckles and vitrectomy are the two main procedures used today to treat retinal detachments, with many surgeons performing a combination of the two.
Latest:
Assessing the impact of FLACS on surgical outcomesFLACS is related to an increase of anterior chamber prostaglandin and cytokines, resulting in intra-operative miosis. This can be prevented by pre-operative non-steroidal anti-inflammatory drug application. As a result of methodological problems, several studies on the association between femtosecond laser-assisted cataract surgery and cystoid macular oedema are inconclusive.
Latest:
Assessing the impact of FLACS on surgical outcomesFLACS is related to an increase of anterior chamber prostaglandin and cytokines, resulting in intra-operative miosis. This can be prevented by pre-operative non-steroidal anti-inflammatory drug application. As a result of methodological problems, several studies on the association between femtosecond laser-assisted cataract surgery and cystoid macular oedema are inconclusive.
Latest:
Outer retinal layer thickness predicts visual acuity in diabetic macular oedemaDiabetes mellitus is a common health problem in developed countries, with diabetic macular oedema (DMO) being a major cause of visual loss. A variety of treatment modalities for DMO are available including laser, steroid and intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents.
Latest:
Diagnosing and treating MacTel degenerative retinal diseaseIdiopathic macular telangiectasia (MacTel) is bilateral condition characterised by ectatic capillaries of the macula and atrophy of the neurosensory retina. Familiarity with the distinctive intraretinal cavitation on SD-OCT in type 2, the most common type, is key for correct diagnosis.
Latest:
Outer retinal layer thickness predicts visual acuity in diabetic macular oedemaDiabetes mellitus is a common health problem in developed countries, with diabetic macular oedema (DMO) being a major cause of visual loss. A variety of treatment modalities for DMO are available including laser, steroid and intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents.
Latest:
Prevent Blindness observes inherited retinal disease genetic testing week May 16-22Prevent Blindness dedicates the third week of May to raising awareness of the benefit of genetic testing, variety of retinal diseases, and available resources.
Latest:
2023: What awaits ophthalmology in the year aheadAs we approach the end of 2022, members of the Ophthalmology Times Europe® Editorial Advisory Board were asked to predict developments in their ophthalmic specialties and interests. A focus is our ageing population, while efficiency and productivity are also on their minds. The board members agree that one of the major challenges in the year to come will be the large number of patients awaiting diagnosis and treatment, which is only going to increase with the rising average life expectancy worldwide.
Latest:
Considering YAG vitreolysis for persistent vitreous floatersStudy evaluates the impact of surgical procedure on visual outcomes in patients
Latest:
SNAPS Eye Shield: Creating the gold standard for postoperative ocular protectionDespite its status as an essential postoperative safety eye product and its utilization by every ocular surgeon with every ocular surgery, eye shield innovation has been neglected to date.
Latest:
OWL Leadership Summit 2023: Navigating ophthalmic leadership challenges and embracing diversityThe Ophthalmic World Leaders (OWL) Leadership Summit, scheduled for September 21 and 22, 2023, in Austin, Texas, will feature a lineup of prominent speakers and engaging discussions on a wide range of leadership topics and industry insights.
Latest:
Elucidating Alzheimer disease pathophysiologyStudy of subjects with rare inherited form of AD shows increased retinal capillary perfusion during the presymptomatic stage.
Latest:
ASRS 2024: External exposures affect retina surgeons’ dexterityNovice surgeons affected more than seasoned surgeons
Latest:
Treating AMD and DME with faricimab: A therapy with lower treatment burdenAccording to physician, this therapeutic may prove to be a treatment option for these diseases.
Latest:
ARVO heads north to Vancouver for 2019 annual meeting‘From the Bench to Bedside and Back’ is focal point for this year’s conference
Latest:
Face-down positioning better after detached retina repairFace-down positioning is associated with a reduction in certain complications following macula-involving retinal displacement (RD) repair, according to researchers.
Latest:
Novel brolucizumab fosters as real-world alternative for nAMDTopline results from phase III studies investigating intravitreal brolucizumab (Novartis) for treatment of neovascular age-related macular degeneration (nAMD) support the potential of this novel anti-VEGF antibody to meet the real-world need for an alternative agent with a sustainable therapeutic regimen.
Latest:
Change for the better? Where the future of surgery may be goingPeter McDonnell, MD, shares his thoughts on Omar R. Shakir's, MD, MBA, article on office-based vitrectomy surgery.
Latest:
Tocilizumab effective for managing posterior segment inflammationImprovement in visual acuity, central retinal thickness, vitreous haze reported at 6 months
Latest:
MCO-010 optogenetic gene therapy for severe vision loss in Stargardt diseaseA mutation-agnostic optogenetic gene therapy is in development using multi-characteristic opsin (MCO) to sensitize the retinal bipolar cells to detect light.
